ARLINGTON, Va., October 1, 2018 — The American Society for Radiation Oncology (ASTRO) announced today the 10 top-rated studies that will be highlighted in the press program for the 2018 ASTRO Annual Meeting. Researchers will present their findings in three news briefings held October 21 through 23 in room 225-D of the Henry B. Gonzalez Convention Center in San Antonio and via live webcast. Reporters can register to cover the meeting and news briefings at http://www.astro.org/ampress.
The briefing schedule is as follows:
Advances in Breast and Lung Cancers
Sunday, October 21, 1:00 – 2:00 p.m. CT
* “Randomized Trial Evaluating Radiation following Surgical Excision for ‘Good Risk’ DCIS: 12-Year Report from NRG/RTOG 9804,” presented by Dr. Beryl McCormick, Memorial Sloan Kettering Cancer Center (Abstract LBA-1)
* “FAST Phase III RCT of Radiation Therapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015),” presented by Dr. Murray Brunt, Institute of Cancer Research, London (Abstract LBA-2)
* “Local Consolidative Therapy (LCT) Improves Overall Survival (OS) Compared to Maintenance Therapy/Observation in Oligometastatic Non-Small Cell Lung Cancer (NSCLC): Final Results of a Multicenter, Randomized, Controlled Phase 2 Trial,” presented by Dr. Daniel Gomez, University of Texas MD Anderson Cancer Center (Abstract LBA-3)
Article originally posted at